Alex Popovych

Shkreli’s biggest blunder was an enormous short position in Orexigen Therapeutics , a La Jolla biopharma firm with an obesity drug. Shkreli shorted 32 million shares of Orexigen on Feb. 1, 2011, when it was

Arch Therapeutics Receives Clearance to Initiate Clinical Trial in Europe
Achieves Milestone in CE Mark Evaluation Process for the AC5 Surgical Hemostatic Device(TM)

OTC

By Traddr

This Wednesday the FED is expected to raise the FED Fund Rate by 25 basis points from 0.25% to 0.50%. If this happens it will be the first rate hike since the summer of 2006, nearly 10 years

This is the world we live in post-2008 financial crisis.
Smartphones, light fixtures and cheap shoes aren’t the only thing made in China. The next global recession might be, too.

August’s international ma

TRADDR.com Trading Community

‪#‎PremiereTrader‬ and TRADDR.com are teaming up for monthly ‪#‎Meetups‬ with Keynote speakers and educational seminars. The first one will be:

Thursday, November 5, 2015
6:30